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attenuates propofol-induced apoptosis 
in developing hippocampal neurons
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Abstract 
Background: We investigated the effect of propofol on the tissue plasminogen activator (tPA) release in developing 
hippocampal neurons, and explored the effects of exogenous tPA on the propofol-induced neuron apoptosis.
Methods: Primary hippocampal neurons isolated from neonatal Sprague-Dawley rats were exposed to propofol (20, 
50, and 100 μM) for 6 h either one time or three times. Finally, neurons were pretreated with exogenous tPA (5 µg/
ml), followed by propofol exposure (100 μM, 6 h). The neuron apoptosis was detected by terminal transferase deoxyu-
ridine triphosphate-biotin nick-end labeling (TUNEL) and the protein expression of cleaved caspase-3 (Cl-Csp3) was 
analyzed by western blot, the tPA in media was tested by enzyme-linked immunosorbent assay.
Results: Propofol exposure significantly increased the number of TUNEL-positive neurons and Cl-Csp3 expression in 
developing hippocampal neurons. Propofol decreased tPA level in the media of developing hippocampal neurons. 
The neuron appotosis induced by propofol was attenuated by pretreatment of tPA.
Conclusion: Propofol exposure decreased tPA release in developing hippocampal neurons. The addition of tPA could 
partially reverse the apoptotic effect of propofol.
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Background
Propofol administered during synaptogenesis can pro-
duce long-term neurobehavioral and functional deficits in 
animals (Creeley et al. 2013; Cattano et al. 2008; Yu et al. 
2013; Li et al. 2014; Xiong et al. 2014), since the develop-
ing brain is more vulnerable to anesthetic-induced neu-
rotoxicity (Cattano et  al. 2008; Jevtovic-Todorovic et  al. 
2003; Fredriksson et al. 2007; Ikonomidou et al. 1999). It 
has been demonstrated recently that proBDNF–p75NTR 
signaling pathway is the key player of propofol and iso-
flurane-induced neurotoxicity (Head et al. 2009; Lemkuil 
et al. 2011; Pearn et al. 2012).
The brain-derived neurotrophic factor (BDNF) is 
stored as a proneurotrophin (proBDNF) within synaptic 
vesicles and is proteolytically cleaved to mature BDNF 
(mBDNF) in the synaptic cleft by plasmin (Lee et  al. 
2001; Keifer et al. 2009; Lu et al. 2006). The mBDNF bind 
with the receptor kinase B and leads to neurite outgrowth 
and synapse stabilization and maturation (Lee et al. 2001; 
Keifer et  al. 2009; Lu et  al. 2005).While the proBDNF 
binds to the p75 neurotrophin receptor (p75NTR) and 
initiates cellular processes that inhibit axonal elongation 
and cause growth cone collapse and apoptosis (Huettner 
and Baughman 1986). The number of plasmin in the syn-
aptic cleft is mainly depending on the tissue plasminogen 
activator (tPA), which convert the plasminogen into plas-
min. When the tPA is decreased, the convertion of plas-
minogen into plasmin may be blunted, and the number of 
proBDNF is increased, which then leads to inhibition of 
axonal elongation, growth cone collapse, and apoptosis.
The release of tPA from presynaptic vesicles is activ-
ity-dependent (Lemkuil et  al. 2011), and it is there-
fore possible that anesthetics might suppress neuronal 
activity, reduce tPA release which finally results in the 
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proBDNF-mediated neuron growth inhibition pathway 
dominant, leading to the final neuronal apoptosis. How-
ever, it is still unknown that the direct effect of propofol 
on the release of tPA in developing neurons, and more 
importantly, whether the addition of exogenous tPA 
could reverse the propofol induced neurotoxicity has not 
been investigated.
We examined whether propofol decreases tPA release, 
which leads to decrease proBDNF, in hippocampal neu-
rons. In addition, we examined whether the addition of 
exogenous tPA attenuates the propopol-induced apopto-
sis in hippocampal neurons.
Methods
The experimental protocols were approved by the animal 
experimental ethics committee of Zhongshan Hospital, 
Fudan University. All experimental procedures were per-
formed in accordance with the Guidelines for the Care 
and Use of Experimental Animals. Hippocampal neurons 
of neonatal Sprague-Dawley rats were isolated by using 
the method described previously. Neurons were isolated 
from the postnatal day 1 or 2 pups and grown in culture 
for 4–6  days in  vitro. Neurons were cultured in media 
(Neuobasal A) supplemented with 250 mM GLUTMax1 
(Santa Cruz, CA), B27 (2  %), and penicillin/streptomy-
cin (1 %). Poly-d-lysine/laminin (2 g/cm2) coated 48-well 
plates were used to culture neurons at 37 °C in 5 % CO2 
before experiments.
Cell culture and treatment
The cultures were placed within an incubator (a gas mixture 
of 5 % CO2, 21 % O2, balance nitrogen at a flow rate of 2 l/
min, 37 °C) and exposed to propofol (20, 50, and 100 μM) 
for 6 h either one time or three times (once per day for 3 
consecutive days). In the multiple exposure groups, the 
neurons were rinsed with PBS for one time after each expo-
sure, and placed in fresh media overnight. Finally, neurons 
were pretreated by recombinant human tPA (Santa Cruz, 
CA) at different concentration (0.05–5 μg/ml) for 15 min, 
followed by propofol 100  μM exposure for 6  h. After 
respective treatments, the neurons were harvested and 
subjected to the following measurements.
TUNEL staining
After each treatment, DNA fragmentation was detected 
for apoptotic neurons by using the fluorometric TUNEL 
system (Roche Nutley, NJ) According to the manufactur-
er’s instructions, neurons were fixed in 4 % paraformalde-
hyde in PBS at room temperature for 20 min, incubated 
with fluorescein-conjugated TdT enzyme at 37 °C for 1 h 
in humidifying chamber, and then mounted with DAPI 
(4′,6′-diamidino-2-phenylindole) for nuclear counter 
staining. Both TUNEL-and DAPI-positive neurons were 
counted by using a Nikon Eclipse 80i fluorescence micro-
scope (Nikon, Tokyo, Japan). Apoptosis rate was quanti-
fied by determining the ratio of TUNEL-positive nuclei 
to total cell nuclei.
tPA ELISA
In brief, after treatment by propofol, media from neurons 
were frozen at −80 °C before preforming enzyme-linked 
immunosorbent assay (ELISA) (Invitrogen, Carlsbad, 
CA). A 48-well plate was precoated with biotinylated 
plasminogen activator inhibitor-1 for 30  min, washed 
three times. The tPA standard (0.05–10 ng/ml) and tested 
samples were added to the plate for 30 min. After incu-
bated with anti-tPA primary antibody and anti-rabbit 
horseradish peroxidase-conjugated secondary antibody 
for 30  min, respectively, the tetramethylbenzidine sub-
strate was added, and the reaction was quenched 10 min 
later by 1 M H2SO4 and read at 450 nm on a spectropho-
tometer (TECAN Infinite M200, San Jose, CA).
Western blot
Briefly, after respective treatments, neurons were lysed 
and 15  μg of proteins were boiled in a sample buffer 
(50  mM Tris–HCl pH 7.5, 150  mM NaCl, 1  % SDS, 
100  mg/mL PMSF) and then separated on 15  % SDS-
PAGE gels. The separated proteins were transferred to 
a nitrocellurose membranes (CNI, Canada), which was 
subsequently blocked in Tris-buffered saline-Tween 20 
(TBST) containing 5 % (w/v) nonfat dried milk for 1 h at 
room temperature. The membrane was then incubated 
with appropriate concentration of primary antibody of 
Cl-Csp3 (1:1000, Vector Laboratories, Burlingame, CA) 
at 4  °C overnight. The membrane was washed and sub-
sequently probed with horseradish per-oxidase-conju-
gated secondary antibody (1:2000, Sigma-Aldrich, St. 
Louis, MO). Blots were finally developed with a chemi-
luminescent HRP substrate kit (Sigma-Aldrich, St. Louis, 
MO, USA) and all protein bands were quantitated with a 
ImageJ version 1.38 (NIH, Bethesda, MD).
Statistical analysis
SPSS16.0 software was used to perform statistical analy-
ses of the data. Statistics were performed using one way 
ANOVA and Student′s t test. All results are expressed as 
the mean ± SD, and P < 0.05 was considered statistically 
significant.
Results
The effects of propofol on neuron apoptosis
The neurons were exposed one and three times to 6 h of 
20, 50, and 100  µM propofol. The number of TUNEL-
positive neurons in propofol-treated group was signifi-
cantly increased when compared with these of control 
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group (P  <  0.05), following one exposure to 50 and 
100 µM propofol but not after a single exposure to 20 µM 
propofol (P  <  0.05) (Fig.  1a). The number of TUNEL-
positive neurons was significantly increased in all propo-
fol-treated groups after three exposures to propofol 
(P  <  0.05) (Fig.  1a). Consistently, the protein expression 
levels of the apoptosis executor cleaved caspase-3 (Cl-
Csp3) were also significantly increased by propofol expo-
sure (P < 0.05) (Fig. 1b).
The effects of propofol on tPA release
The neurons were exposed one and three times to 6  h 
of 20, 50, and 100  µM propofol. The tPA in the media 
was tested by ELISA. Compared with the control group, 
neurons exposed to propofol had less tPA in the media 
(P < 0.05) (Fig. 2).
The effects of tPA addition on propofol‑induced appotosis
The neurons were pretreated with increasing doses of tPA 
(0.05–5 µg/ml) before exposed one time to 6 h of 100 µM 
propofol. Increasing doses of tPA decreased propofol-
induced apoptosis rate and Cl-Csp3 expression with a 
maximum decrease at 5 µg/ml (P < 0.05) (Fig. 3a, b).
Discussion
The data from the present study indicated that propofol 
could induce apoptosis in cultured developing hippocam-
pal neurons, which are consistent with the findings from 
the previous studies (Yu et al. 2013; Pearn et al. 2012; Liu 
et  al. 2014; Twaroski et  al. 2014). Importantly, propofol 
exposure decreases tPA release, and the administration 
of exogenous tPA attenuates propofol-induced neuron 
apoptosis.
The new neurons from postnatal hippocampus play an 
important role in cognitive processes such as learning 
and memory. It has been reported that anesthetics lead 
to neurodegeneration during synaptogenesis, which is 
on the postnatal day 5–7 (Jevtovic-Todorovic et al. 2003).
Therefore, in the present study, the isolated hippocampal 
neurons (postnatal day 1 or 2 pups of rats) were cultured 
for 4–6  days in  vitro, and then undergoing respec-
tive treatments. The estimated brain concentrations of 
propofol in humans during the induction and mainte-
nance of general anesthesia ranges from 22 to 112  μM 
(Vutskits et  al. 2005; Chung et  al. 2013; Ludbrook et  al. 
2002; Costela et al. 1996), and the blood concentration of 
propofol for the induction of anesthesia and maintenance 
typically ranges from about 5 to 60 μM in children (Vivi-
and et al. 2003; Varveris and Morton 2002; Hume-Smith 
et al. 2008).Based on these findings, the propofol concen-
trations used in our study were 20, 50 and 100 μM, and 
the neuron apoptosis was prominent at propofol 50 μM, 
which seems clinically significant. In addition, given 
Fig. 1 Propofol induces appotosis in cultured developing hippocam-
pal neurons. The neurons were exposed one or three times to 6 h of 
20, 50, and 100 µM propofol. After treatments, the TUNEL-positive 
neurons and the protein expression of Cl-Csp3 were analyzed by 
TUNEL staining (a) and western blot (b), respectively. Densitometric 
analysis of Cl-Csp3 protein was performed after normalization with 
β-actin (b). *,▲ P < 0.05 vs C1 or C2. C1 control group of single expo-
sure to propofol, C2 control group of multiple exposure to propofol
Fig. 2 The effects of propofol on tPA release
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propofol was dissolved in DMSO to exclude the poten-
tial impact of emulsion, equal volume of DMSO (the 
final concentration of DMSO was adjusted to 0.005 % for 
each solution to avoid its possible nonspecific action) was 
added as the vehicle control in each treatment.
The clinically used tPA (Actilyse®) is the approved drug 
for the acute treatment of ischemic stroke. Unfortunately, 
the narrow therapeutic window of tPA-induced throm-
bolysis and the risk of hemorrhage limited its use in clini-
cal practice (Zhang et al. 2011; Saqqur et al. 2008). It also 
has been reported that tPA might endanger endothelial 
cells and neurons, resulting in an alteration of the integ-
rity of components of the neurovascular unit (Yepes et al. 
2009). In addition, intravenously administerd tPA can 
induce excitotoxic brain damage in rodents with intact 
or damaged blood–brain barrier (Benchenane et al. 2005; 
Lopez-Atalaya et  al. 2007). However, the effects of tPA 
in reversing the neurotoxicity in developing neurons 
have not been reported in  vivo and vitro. On the other 
hand, the involvement of p75NTR in propofol-induced 
neurotoxicity has been demonstrated recently, which 
was verified by p75NTR blockade and knockout (Pearn 
et  al. 2012). Thus,we investgated the effects of propofol 
on the upstream signals of this pathway. Our data indi-
cated that propofol reduced the amount of tPA present 
in culture media of developing hippocampal neurons. 
This reduction in tPA may be due to neuronal suppres-
sion by propofol, since tPA release from neurons is in an 
activity-dependent manner (Baranes et al. 1998; Lochner 
et  al. 2008; Gualandris et  al. 1996) and the well-known 
neuron activity depression effects of general anesthetics. 
After the inhibiting effects of propofol on tPA release in 
developing hippocampal neurons was verified, we fur-
ther found that exogenous addition of tPA can partially 
reverse the propofol-induced neuron apoptosis.
In addition to direct plasminogen proteolytic function, 
tPA could also bind to the low density lipoprotein recep-
tor expressed in neurons, which induces the ERK1/2 
and Akt mediated antiapoptotic effects (Hu et  al. 2008; 
An et  al. 2008). The urokinase-like plasmingoen activa-
tor receptor also can be binded by tPA and initiating the 
intracellular antiapoptotic signaling (Maupas-Schwalm 
et al. 2004). These findings may indicated that tPA addi-
tion not only making the mBDNF-mediated neuron 
growth promoting pathway dominant, but also initiating 
the anti-apoptotic effects by other pathways, which need 
to be elucidated in the future study. Another limitation 
of our study is that we did not investigate the effects of 
popofol or the different treatments on the growth of neo-
natal neurons, such as total number of dendrites, num-
ber of primary dendrites, and dendrite length. Moreover, 
the current study was performed in  vitro, whether tPA 
administration also can attenuate apoptosis induced by 
propofol in developing neurons in vivo are the purpose of 
our further study.
Conclusion
Our study demostrated that propofol decreases tPA 
release in developing hippocampal neurons, and the 
addition of tPA could partially reverse the pro-apoptotic 
effect of propofol. Those findings may project new light 
on the basis of preventing the propofol-induced neuro-
toxicity in developing neurons.
Authors’ contributions
The present study was designed and accomplished by CL, JC, and ZX. MD and 
FD were responsible for the research work flow. All authors read and approved 
the final manuscript.
Acknowledgements
This work was supported by the Natural Science Foundation of China (Grant 
No. 81400930), Youth Foundation of shanghai municipal commission of health 
and family (Grant No. 20144Y0234), Youth Foundation of zhongshang hospital 
Fig. 3 tPA addition attenuates appotosis induced by propofol in 
cultured developing hippocampal neurons. The neurons were pre-
treated with increasing doses of tPA (0.05 to 5 µg/ml) before exposed 
one time to 6 h of propofol 100 µM. After treatments, the TUNEL-pos-
itive neurons and the protein expression of Cl-Csp3 were analyzed by 
TUNEL staining (a) and western blots (b), respectively. Densitometric 
analysis of Cl-Csp3 protein was performed after normalization with 
β-actin (b). * P < 0.05 vs Propofol group
Page 5 of 5Liang et al. SpringerPlus  (2016) 5:475 
(Grant No. 2014ZSQN27), and Excellent Youth project of zhongshang hospital 
(Grant No. 2015ZSYXQ N19).
Competing interests
The authors declare that they have no competing interests.
Received: 23 February 2016   Accepted: 2 April 2016
References
An J, Zhang C, Polavarapu R et al (2008) Tissue-type plasminogen activator 
and the low-density lipoprotein receptor-related protein induce Akt 
phosphorylation in the ischemic brain. Blood 112:2787–2794
Baranes D, Lederfein D, Huang YY et al (1998) Tissue plasminogen activator 
contributes to the late phase of LTP and to synaptic growth in the hip-
pocampal mossy fiber pathway. Neuron 21:813–825
Benchenane K, Berezowski V, Ali C et al (2005) Tissue-type plasminogen 
activator crosses the intact blood-brain barrier by low-density lipo-
protein receptor-related protein-mediated transcytosis. Circulation 
111:2241–2249
Cattano D, Young C, Straiko MM et al (2008) Subanesthetic doses of propofol 
induce neuroapoptosis in the infant mouse brain. Anesth Analg 
106:1712–1714
Chung HG, Myung SA, Son HS et al (2013) In vitro effect of clinical propofol 
concentrations on platelet aggregation. Artif Organs 37:E51–E55
Costela JL, Jimenez R, Calvo R et al (1996) Serum protein binding of propofol 
in patients with renal failure or hepatic cirrhosis. Acta Anaesthesiol Scand 
40:741–745
Creeley C, Dikranian K, Dissen G et al (2013) Propofol-induced apoptosis of 
neurones and oligodendrocytes in fetal and neonatal rhesus macaque 
brain. Br J Anaesth 110(Suppl 1):i29–i38
Fredriksson A, Ponten E, Gordh T et al (2007) Neonatal exposure to a combina-
tion of N-methyl-D-aspartate and gamma-aminobutyric acid type A 
receptor anesthetic agents potentiates apoptotic neurodegeneration 
and persistent behavioral deficits. Anesthesiology 107:427–436
Gualandris A, Jones TE, Strickland S et al (1996) Membrane depolarization 
induces calcium-dependent secretion of tissue plasminogen activator. J 
Neurosci 16:2220–2225
Head BP, Patel HH, Niesman IR et al (2009) Inhibition of p75 neurotrophin 
receptor attenuates isoflurane-mediated neuronal apoptosis in the neo-
natal central nervous system. Anesthesiology 110:813–825
Hu K, Lin L, Tan X et al (2008) tPA protects renal interstitial fibroblasts and 
myofibroblasts from apoptosis. J Am Soc Nephrol 19:503–514
Huettner JE, Baughman RW (1986) Primary culture of identified neurons from 
the visual cortex of postnatal rats. J Neurosci 6:3044–3060
Hume-Smith HV, Sanatani S, Lim J et al (2008) The effect of propofol concen-
tration on dispersion of myocardial repolarization in children. Anesth 
Analg 107:806–810
Ikonomidou C, Bosch F, Miksa M et al (1999) Blockade of NMDA receptors and 
apoptotic neurodegeneration in the developing brain. Science 283:70–74
Jevtovic-Todorovic V, Hartman RE, Izumi Y et al (2003) Early exposure to 
common anesthetic agents causes widespread neurodegeneration 
in the developing rat brain and persistent learning deficits. J Neurosci 
23:876–882
Keifer J, Sabirzhanov BE, Zheng Z et al (2009) Cleavage of proBDNF to BDNF 
by a tolloid-like metalloproteinase is required for acquisition of in vitro 
eyeblink classical conditioning. J Neurosci 29:14956–14964
Lee R, Kermani P, Teng KK et al (2001) Regulation of cell survival by secreted 
proneurotrophins. Science 294:1945–1948
Lemkuil BP, Head BP, Pearn ML et al (2011) Isoflurane neurotoxicity is mediated 
by p75NTR-RhoA activation and actin depolymerization. Anesthesiology 
114:49–57
Li J, Xiong M, Alhashem HM et al (2014) Effects of prenatal propofol exposure 
on postnatal development in rats. Neurotoxicol Teratol 43:51–58
Liu F, Rainosek SW, Sadovova N et al (2014) Protective effect of acetyl-L-
carnitine on propofol-induced toxicity in embryonic neural stem cells. 
Neurotoxicology 42:49–57
Lochner JE, Spangler E, Chavarha M et al (2008) Efficient copackaging and 
cotransport yields postsynaptic colocalization of neuromodulators asso-
ciated with synaptic plasticity. Dev Neurobiol 68:1243–1256
Lopez-Atalaya JP, Roussel BD, Ali C et al (2007) Recombinant Desmodus 
rotundus salivary plasminogen activator crosses the blood–brain barrier 
through a low-density lipoprotein receptor-related protein-dependent 
mechanism without exerting neurotoxic effects. Stroke 38:1036–1043
Lu B, Pang PT, Woo NH (2005) The yin and yang of neurotrophin action. Nat 
Rev Neurosci 6:603–614
Lu LX, Yon JH, Carter LB et al (2006) General anesthesia activates BDNF-
dependent neuroapoptosis in the developing rat brain. Apoptosis 
11:1603–1615
Ludbrook GL, Visco E, Lam AM (2002) Propofol: relation between brain con-
centrations, electroencephalogram, middle cerebral artery blood flow 
velocity, and cerebral oxygen extraction during induction of anesthesia. 
Anesthesiology 97:1363–1370
Maupas-Schwalm F, Auge N, Robinet C et al (2004) The sphingomyelin/cera-
mide pathway is involved in ERK1/2 phosphorylation, cell proliferation, 
and uPAR overexpression induced by tissue-type plasminogen activator. 
FASEB J 18:1398–1400
Pearn ML, Hu Y, Niesman IR et al (2012) Propofol neurotoxicity is mediated by 
p75 neurotrophin receptor activation. Anesthesiology 116:352–361
Saqqur M, Tsivgoulis G, Molina CA et al (2008) Symptomatic intracerebral hem-
orrhage and recanalization after IV rt-PA: a multicenter study. Neurology 
71:1304–1312
Twaroski DM, Yan Y, Olson JM et al (2014) Down-regulation of microRNA-21 is 
involved in the propofol-induced neurotoxicity observed in human stem 
cell-derived neurons. Anesthesiology 121:786–800
Varveris DA, Morton NS (2002) Target controlled infusion of propofol for induc-
tion and maintenance of anaesthesia using the paedfusor: an open pilot 
study. Paediatr Anaesth 12:589–593
Viviand X, Berdugo L, De La Noe CA et al (2003) Target concentration of 
propofol required to insert the laryngeal mask airway in children. Paediatr 
Anaesth 13:217–222
Vutskits L, Gascon E, Tassonyi E et al (2005) Clinically relevant concentrations 
of propofol but not midazolam alter in vitro dendritic development of 
isolated gamma-aminobutyric acid-positive interneurons. Anesthesiol-
ogy 102:970–976
Xiong M, Li J, Alhashem HM et al (2014) Propofol exposure in pregnant rats 
induces neurotoxicity and persistent learning deficit in the offspring. 
Brain Sci 4:356–375
Yepes M, Roussel BD, Ali C et al (2009) Tissue-type plasminogen activator in 
the ischemic brain: more than a thrombolytic. Trends Neurosci 32:48–55
Yu D, Jiang Y, Gao J et al (2013) Repeated exposure to propofol potentiates 
neuroapoptosis and long-term behavioral deficits in neonatal rats. 
Neurosci Lett 534:41–46
Zhang B, Sun XJ, Ju CH (2011) Thrombolysis with alteplase 4.5-6 hours after 
acute ischemic stroke. Eur Neurol 65:170–174
